Talon Compounding Injectable Sterility Recall
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling an injectable steroid combination product due to lack of assurance of sterility. The recall affects 13 vials distributed across the United States, including Washington, D.C. and Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a sterile injectable product without confirmed reports of illness. Lack of sterility assurance in injectable medications poses serious potential harm to patients including infection and sepsis, meeting the Severe criteria for Class II recalls involving risk of serious injury.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE due to lack of assurance of sterility. The recalled product is a prescription injectable medication.
The recall involves 13 vials across three lots: Lot T1007072021:98 (BUD 01/03/2022), Lot T1005252021:31 (BUD 11/21/2021), and Lot T1009222021:60 (BUD 03/21/2022). The product was distributed throughout the United States, including Washington, D.C. and Puerto Rico.
Patients who have received this product should consult their healthcare provider or pharmacist. Healthcare providers and patients should not use any remaining product from the affected lots.
The recalled product
- Product
- TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Hazard
- lack-of-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot: T1007072021:98 BUD: 01/03/2022
- T1005252021:31 BUD: 11/21/2021
- T1009222021:60 BUD: 03/21/2022
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27